[HTML][HTML] Emerging concepts of miRNA therapeutics: from cells to clinic

C Diener, A Keller, E Meese - Trends in Genetics, 2022 - cell.com
MicroRNAs (miRNAs) are very powerful genetic regulators, as evidenced by the fact that a
single miRNA can direct entire cellular pathways via interacting with a broad spectrum of …

[HTML][HTML] Pulmonary delivery of siRNA against acute lung injury/acute respiratory distress syndrome

M Zoulikha, Q Xiao, GF Boafo, MA Sallam… - … Pharmaceutica Sinica B, 2022 - Elsevier
The use of small interfering RNAs (siRNAs) has been under investigation for the treatment of
several unmet medical needs, including acute lung injury/acute respiratory distress …

[HTML][HTML] Nanotechnology advances in the detection and treatment of cancer: an overview

S Mosleh-Shirazi, M Abbasi, M reza Moaddeli… - …, 2022 - ncbi.nlm.nih.gov
Over the last few years, progress has been made across the nanomedicine landscape, in
particular, the invention of contemporary nanostructures for cancer diagnosis and …

[HTML][HTML] A perspective on oligonucleotide therapy: Approaches to patient customization

S Thakur, A Sinhari, P Jain, HR Jadhav - Frontiers in Pharmacology, 2022 - frontiersin.org
It is estimated that the human genome encodes 15% of proteins that are considered to be
disease-modifying. Only 2% of these proteins possess a druggable site that the approved …

[HTML][HTML] Therapeutic siRNA: state-of-the-art and future perspectives

M Friedrich, A Aigner - BioDrugs, 2022 - Springer
The highly specific induction of RNA interference-mediated gene knockdown, based on the
direct application of small interfering RNAs (siRNAs), opens novel avenues towards …

Nebulization of extracellular vesicles: a promising small RNA delivery approach for lung diseases

Y Han, Y Zhu, HA Youngblood, S Almuntashiri… - Journal of Controlled …, 2022 - Elsevier
Small extracellular vesicles (sEVs) are a group of cell-secreted nanovesicles with a diameter
up to 200 nm. A growing number of studies have indicated that sEVs can reflect the …

Lipid Nanoparticle (LNP) Chemistry Can Endow Unique In Vivo RNA Delivery Fates within the Liver That Alter Therapeutic Outcomes in a Cancer Model

LT Johnson, D Zhang, K Zhou, SM Lee… - Molecular …, 2022 - ACS Publications
Within the field of lipid nanoparticles (LNPs) for RNA delivery, the focus has been mainly
placed on organ level delivery, which can mask cellular level effects consequential to …

RNA cancer nanomedicine: nanotechnology-mediated RNA therapy

BE Ferdows, DN Patel, W Chen, X Huang, N Kong… - Nanoscale, 2022 - pubs.rsc.org
It has been demonstrated that RNA molecules—mRNA, siRNA, microRNA, and sgRNA—
regulate cancer-specific genes, and therefore, RNA-based therapeutics can suppress tumor …

Aptamer-conjugated nanoliposomes containing COL1A1 siRNA sensitize CRC cells to conventional chemotherapeutic drugs

H Manoochehri, A Jalali, H Tanzadehpanah… - Colloids and Surfaces B …, 2022 - Elsevier
COL1A1 is an important extracellular matrix component that is associated with poor
prognosis in cancers. In this study, As1411 aptamer-conjugated liposomes were used for …

[HTML][HTML] Gene therapy to enhance angiogenesis in chronic wounds

E Shaabani, M Sharifiaghdam, R Faridi-Majidi… - … Therapy-Nucleic Acids, 2022 - cell.com
Skin injuries and chronic non-healing wounds are one of the major global burdens on the
healthcare systems worldwide due to their difficult-to-treat nature, associated co-morbidities …